Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-29

FDA Approved: MESALAMINE — Supplemental Application (Lannett Company Inc.)

View source ↗

Summary

FDA approved a supplemental application for Mesalamine (generic) from Lannett Company Inc., for the treatment of ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

SUPPL AP for MESALAMINE (MESALAMINE)